• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.印度南部一家三级护理医院上报的药物不良反应评估:一项回顾性横断面研究。
Int J Pharm Investig. 2017 Oct-Dec;7(4):193-197. doi: 10.4103/jphi.JPHI_81_17.
2
Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.WHO- Uppsala 监测中心系统与 Naranjo 算法评估药物不良反应因果关系的一致性研究。
J Pharmacol Toxicol Methods. 2024 May-Jun;127:107514. doi: 10.1016/j.vascn.2024.107514. Epub 2024 May 18.
3
Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions.世界卫生组织药物不良反应因果关系评估量表与纳伦霍算法在药物不良反应因果关系评估方面的一致性。
J Family Med Prim Care. 2021 Sep;10(9):3303-3308. doi: 10.4103/jfmpc.jfmpc_831_21. Epub 2021 Sep 30.
4
Comparison of different methods for causality assessment of adverse drug reactions.不同药物不良反应因果关系评估方法的比较
Int J Clin Pharm. 2018 Aug;40(4):903-910. doi: 10.1007/s11096-018-0694-9. Epub 2018 Jul 26.
5
A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.一项关于纳伦霍算法与世界卫生组织药物不良反应因果关系评估协作中心标准之间一致性的研究。
Indian J Pharmacol. 2014 Jan-Feb;46(1):117-20. doi: 10.4103/0253-7613.125192.
6
Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.WHO-UMC 量表与 Naranjo 量表评估报告药物不良反应关联性的比较。
J Patient Saf. 2024 Jun 1;20(4):236-239. doi: 10.1097/PTS.0000000000001213. Epub 2024 Feb 12.
7
Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.急性冠脉综合征患者中药物不良反应的模式和分布研究。
Indian J Med Res. 2022 Jul;156(1):111-121. doi: 10.4103/ijmr.IJMR_1275_20.
8
Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.两种药物不良反应因果关系评估方法的评分者间一致性:利物浦药物不良反应因果关系评估工具与世界卫生组织-乌普萨拉监测中心系统的随机比较
PLoS One. 2017 Feb 24;12(2):e0172830. doi: 10.1371/journal.pone.0172830. eCollection 2017.
9
Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.采用共识性专家判断作为参考,比较三种方法(更新的逻辑概率法、Naranjo 和利物浦算法)评估常规药物警戒病例报告。
Drug Saf. 2013 Oct;36(10):1033-44. doi: 10.1007/s40264-013-0083-1.
10
Causality assessment of adverse drug reactions in neonates: a comparative study between Naranjo's algorithm and Du's tool.新生儿药物不良反应的因果关系评估:Naranjo 算法与 Du 工具的比较研究。
Int J Clin Pharm. 2023 Aug;45(4):1007-1013. doi: 10.1007/s11096-023-01595-9. Epub 2023 May 22.

引用本文的文献

1
Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study.钦奈一家三级护理医院记录的药物不良反应的探索与评估:一项深入的回顾性观察研究。
Cureus. 2024 May 24;16(5):e60977. doi: 10.7759/cureus.60977. eCollection 2024 May.
2
The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database.包括中枢神经系统药物在内的处方药在导致男性因素不育(MFI)方面的潜在作用:对美国食品药品监督管理局(FDA)药物警戒数据库的评估。
Brain Sci. 2023 Nov 29;13(12):1652. doi: 10.3390/brainsci13121652.
3
Causality and avoidability of adverse drug reactions of antibiotics in hospitalized children: a cohort study.抗生素致住院患儿不良反应的因果关系与可避免性:队列研究。
Int J Clin Pharm. 2021 Oct;43(5):1293-1301. doi: 10.1007/s11096-021-01249-8. Epub 2021 Mar 3.
4
Use of polymyxin B in patients with renal impairment: A retrospective examination of 5 cases.多粘菌素B在肾功能损害患者中的应用:5例回顾性研究。
Exp Ther Med. 2020 Nov;20(5):89. doi: 10.3892/etm.2020.9217. Epub 2020 Sep 11.

本文引用的文献

1
Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.两种药物不良反应因果关系评估方法的评分者间一致性:利物浦药物不良反应因果关系评估工具与世界卫生组织-乌普萨拉监测中心系统的随机比较
PLoS One. 2017 Feb 24;12(2):e0172830. doi: 10.1371/journal.pone.0172830. eCollection 2017.
2
Causality assessment of adverse drug reaction in Pulmonology Department of a Tertiary Care Hospital.三级护理医院呼吸内科药物不良反应的因果关系评估
J Basic Clin Pharm. 2015 Jun;6(3):84-8. doi: 10.4103/0976-0105.160744.
3
Adverse drug reactions causing hospital admissions in childhood: a prospective, observational, single-centre study.导致儿童住院的药物不良反应:一项前瞻性、观察性、单中心研究。
Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):560-4. doi: 10.1111/bcpt.12264. Epub 2014 May 26.
4
A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.一项关于纳伦霍算法与世界卫生组织药物不良反应因果关系评估协作中心标准之间一致性的研究。
Indian J Pharmacol. 2014 Jan-Feb;46(1):117-20. doi: 10.4103/0253-7613.125192.
5
Clinical causality assessment for adverse drug reactions.药物不良反应的临床因果关系评估
Indian J Anaesth. 2013 May;57(3):325-6. doi: 10.4103/0019-5049.115608.
6
Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.利物浦药物不良反应因果关系评估工具的开发和评分者间信度。
PLoS One. 2011;6(12):e28096. doi: 10.1371/journal.pone.0028096. Epub 2011 Dec 14.
7
Adverse drug reaction and causality assessment scales.药物不良反应及因果关系评估量表
Lung India. 2011 Apr;28(2):152-3. doi: 10.4103/0970-2113.80343.
8
Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel.药物不良反应的因果关系评估:已发表决策算法得出的结果与专家小组评估结果的比较
Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):885-90. doi: 10.1002/pds.1138.
9
Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability.药物不良反应的因果关系评估:根据不同程度的可归因性,比较从已发表的决策算法和专家小组评估中获得的结果。
J Clin Pharm Ther. 2003 Apr;28(2):137-43. doi: 10.1046/j.1365-2710.2003.00475.x.
10
Counting the costs of drug-related adverse events.计算药物相关不良事件的成本。
Pharmacoeconomics. 1999 May;15(5):445-58. doi: 10.2165/00019053-199915050-00003.

印度南部一家三级护理医院上报的药物不良反应评估:一项回顾性横断面研究。

An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study.

作者信息

Gupta Sandeep Kumar, Kumar K Deva

机构信息

Department of Pharmacology, Heritage Institute of Medical Sciences, Varanasi, Uttar Pradesh, India.

Department of Pharmacology, Dhanalakshmi Srinivasan Medical College and Hospital, Perambalur, Tamil Nadu, India.

出版信息

Int J Pharm Investig. 2017 Oct-Dec;7(4):193-197. doi: 10.4103/jphi.JPHI_81_17.

DOI:10.4103/jphi.JPHI_81_17
PMID:29692979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5903024/
Abstract

OBJECTIVE

The primary objective of this study was to assess the causality of ADRs using World Health Organization-Uppsala Monitoring Centre (WHO-UMC), Naranjo and Liverpool ADR Causality Assessment Tool (LCAT). Other primary objective was to assess the agreement between the WHO-UMC criterion, Naranjo algorithm and LCAT. The secondary objective was to assess the reported adverse drug reactions in a tertiary care hospital in South India.

MATERIALS AND METHODS

This was a cross-sectional retrospective study. All the ADRs which were reported by the Pharmacovigilance Unit between July 2016 and March 2017 were assessed. Causality assessment was performed by two well-trained independent pharmacologists by applying the three methods-WHO, Naranjo and LCAT. Concurrence between the two algorithms was compared using the Cohen's weighted kappa statistic.

RESULTS

Causality assessment of adverse reactions according to Naranjo criteria shows that 81% cases were of probable type, 9.5% cases were possible and 9.5% cases were unlikely. Causality assessment of adverse reactions according to WHO-UMC criteria shows that 85.7% cases were of probable type, 4.8% cases were possible, 4.8% cases were unlikely and 4.8% cases were definite. Causality assessment of adverse reactions according to Liverpool criteria shows that 61.9% cases were of probable type, 4.8% cases were possible and 33.3% cases were definite. Cohen's kappa test shows that negative and poor concurrence was seen between WHO and Naranjo causality comparison (κ = -0.161). Positive but poor concurrence based on kappa values was seen between Liverpool and Naranjo's causality comparison (κ = 0.133). Negative and poor concurrence based on kappa values was seen between WHO and Liverpool causality comparison (κ = -0.161).

CONCLUSION

The most frequent causality category observed by the WHO-UMC criteria, Naranjo as well as the Liverpool algorithm was "Probable." Full concurrence was not found between any of two scales of causality assessment.

摘要

目的

本研究的主要目的是使用世界卫生组织-乌普萨拉监测中心(WHO-UMC)、纳朗霍和利物浦药物不良反应因果关系评估工具(LCAT)评估药物不良反应的因果关系。其他主要目的是评估WHO-UMC标准、纳朗霍算法和LCAT之间的一致性。次要目的是评估印度南部一家三级护理医院报告的药物不良反应。

材料与方法

这是一项横断面回顾性研究。对药物警戒部门在2016年7月至2017年3月期间报告的所有药物不良反应进行评估。由两名训练有素的独立药理学家应用WHO、纳朗霍和LCAT这三种方法进行因果关系评估。使用科恩加权kappa统计量比较两种算法之间的一致性。

结果

根据纳朗霍标准对不良反应进行的因果关系评估显示,81%的病例为很可能类型,9.5%的病例为可能类型,9.5%的病例为不太可能类型。根据WHO-UMC标准对不良反应进行的因果关系评估显示,85.7%的病例为很可能类型,4.8%的病例为可能类型,4.8%的病例为不太可能类型,4.8%的病例为肯定类型。根据利物浦标准对不良反应进行的因果关系评估显示,61.9%的病例为很可能类型,4.8%的病例为可能类型,33.3%的病例为肯定类型。科恩kappa检验显示,WHO与纳朗霍因果关系比较之间存在负向且一致性差的情况(κ = -0.161)。利物浦与纳朗霍因果关系比较之间基于kappa值存在正向但一致性差的情况(κ = 0.133)。WHO与利物浦因果关系比较之间基于kappa值存在负向且一致性差的情况(κ = -0.161)。

结论

WHO-UMC标准、纳朗霍以及利物浦算法观察到的最常见因果关系类别是“很可能”。在任何两种因果关系评估量表之间均未发现完全一致的情况。